A new standard of care for the treatment of chemotherapy-induced diarrhea in dogs

EP: 1.The extraordinary value of veterinary dermatology specialists to general practitioners with Julia Miller

EP: 2.Light-based therapy for postoperative wound healing and more

EP: 3.Animal toxicity treatment with Erik Zager

EP: 4.Targeted therapy for canine osteoarthritis

Now Viewing

EP: 5.A new standard of care for the treatment of chemotherapy-induced diarrhea in dogs

EP: 6.How Dr Sue Ettinger treated chemotherapy-induced diarrhea in this intrapelvic sarcoma patient

EP: 7.The power of noninvasive shock wave therapy for pain management and rehabilitation

EP: 8.Endocrinology, thyroid, and breakthroughs in testing

EP: 9.Topical therapy: a critical piece of the dermatology puzzle

EP: 10.Breaking down the Nextmune line of topical dermatologic products

EP: 11.The next generation of allergy testing and immunotherapy

EP: 12.Creating inclusive spaces for the LGBTQ+ community in vet med

EP: 13.AI brings the reference lab into the clinic

EP: 14.How to inspire the next generation of veterinarians

EP: 15.Why shadowing makes all the difference for nurturing a career in vet med

EP: 16.The future of data-driven veterinary care

EP: 17.How digital cytology is bridging the gap for quality control and efficiency

EP: 18.Tackling canine separation anxiety with Dr Christopher Pachel

EP: 19.See the Calmer Canine separation anxiety treatment system in action

EP: 20.No-touch vitals monitoring for stress-free post-op recovery

EP: 21.The multimodal approach to the itchy pet: treating from a "whole-animal" perspective

EP: 22.Examining antimicrobial stewardship in veterinary dermatology

This content is sponsored by Jaguar Health.

In this segment of dvm360 Live!™, Sue Ettinger, DVM, DACVIM (oncology), introduces crofelemer delayed-release tablets (Canalevia-CA1) and explains how it works to control chemotherapy-induced canine diarrhea.

The following is a partial transcript. See the full video for more:

Sue Ettinger, DVM, DACVIM (oncology): [Canalevia-CA1] is locally acting, and it's an antisecretory drug. It works on the chloride channels to restore water balance, so they don't have that watery diarrhea.

Adam Christman, DVM, MBA: Can general practitioners prescribe this?

Sue Ettinger, DVM, DACVIM (oncology): Yes, just remember it's FDA-approved only for chemotherapy-induced diarrhea.